The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus
Author(s) -
William Stohl
Publication year - 2017
Publication title -
journal of rheumatic diseases
Language(s) - English
Resource type - Journals
eISSN - 2093-940X
pISSN - 2233-4718
DOI - 10.4078/jrd.2017.24.2.65
Subject(s) - b cell activating factor , belimumab , medicine , clinical trial , immunology , systemic lupus erythematosus , b cell , oncology , antibody , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom